Authors: REFINO CJ MODI NB BULLENS S PATER C LIPARI MT ROBARGE K BLACKBURN B BERESINI M WELLER T STEINER B BUNTING S

Citation: Cj. Refino et al., PHARMACOKINETICS, PHARMACODYNAMICS AND TOLERABILITY OF A POTENT, NONPEPTIDIC, GP IIB IIIA RECEPTOR ANTAGONIST FOLLOWING MULTIPLE ORAL ADMINISTRATIONS OF A PRODRUG FORM/, Thrombosis and haemostasis, 79(1), 1998, pp. 169-176

Authors: DEGUZMAN L REFINO CJ STEINMETZ H BULLENS S LIPARI T SMYTH R EATON D BUNTING S

Citation: L. Deguzman et al., INHIBITION OF TISSUE FACTOR OR INTRINSIC XASE ARE EFFECTIVE ANTITHROMBOTIC STRATEGIES IN A NEW MODEL OF VENOUS THROMBOSIS, Thrombosis and haemostasis, 1997, pp. 1194-1194

Authors: REFINO C MODI N BULLENS S PATER C LIPARI T WU D BLACKBURN B WELLER T STEINER B BUNTING S

Citation: C. Refino et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF A POTENT, NONPEPTIDIC, GP IIB-IIIA RECEPTOR ANTAGONIST (RO-44-3888) FOLLOWING ORAL-ADMINISTRATION OF A PRODRUG FORM (RO-48-3657) TO RHESUS-MONKEYS, Blood, 86(10), 1995, pp. 348-348